Complete Response with weekly Paclitaxel and Cetuximab in a Patient with Pulmonary Metastasis of Laryngeal Cancer
Journal: Austin Journal of Medical Oncology (Vol.2, No. 3)Publication Date: 2015-09-15
Authors : David Gutiérrez; Blanca Ludeña; Guillermo Plaza;
Page : 1-3
Keywords : Squamous Cell Laryngeal Carcinoma; Metastatic Disease; Cetuximab; Complete Response;
Abstract
We present a case of a 71 years old man with a metastatic squamous cell laryngeal carcinoma after local complete response with chemoradiotherapy and 24 months of disease free survival. Metastatic disease was treated with a combination of chemotherapy paclitaxel weekly schedule and the anti epidermal grouth factor inhibitor monoclonal antibody cetuximab.A very early and maintained complete response was achieved. We will discuss about the necessity of predictive and good prognosis biomarkers on laringeal tumours which can explain long survivors.
Other Latest Articles
- A Prospective Phase III Open Label Study Comparing Low Dose Paclitaxel Versus Cisplatin as Weekly Regimen with Concurrent Radiation in Locally Advanced Head and Neck Cancer
- GEOCHEMICAL FACTOR OF MARSHALLITES LOCALIZATION IN MAGNETITE QUARTZITES CRUST OF WEATHERING IN THE KRYVYI RIH BASIN
- Coexistence of Acute Lymphoblastic Leukemia with Lupus Erythematosus in a Male Child: A Rarest of Rare Association
- ZONAL CRYSTALS OF BRITHOLITE: METASOMATISM OR CRYSTALLIZATION?
- Benign Pulmonary Metastasizing Leiomyoma of Uterus Presenting as Malignancy of Unknown Origin, A Diagnostic Dilemma
Last modified: 2017-05-25 18:33:52